 | BridgeBio Pharma, Inc. | |||
| NMS : BBIO || Location: United States | ||||
$24.74-0.21 (-0.84%) |
2.03 M | 24.27 - 25.35 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 14.281 M |
| March 15, 2024 | 13.407 M |
| Feb. 29, 2024 | 13.636 M |
| Feb. 15, 2024 | 14.004 M |
| Jan. 31, 2024 | 14.209 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.93 | -0.96 | -3.37% |
| 09/30/2023 | -0.83 | -1.08 | -29.82% |
| 06/30/2023 | -0.85 | -0.98 | -15.29% |
| 03/31/2023 | -0.85 | -0.92 | -8.53% |
| 12/31/2022 | -0.87 | -0.92 | -5.83% |
BBIO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 184.452M | Shares Float | 113.025M |
| Short Float | 14.281M | Market Cap | 4563.34M |
| Institution ownership | 92.14% | Insider ownership | 5.369% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.95 | Forward EPS | -3.03 |